Radiomics approaches have been successfully used to predict the Ki-67 index in various types of solid tumors, including breast cancer, non-small cell lung cancer, intrahepatic cholangiocarcinoma, glioma subtypes, and gastric cancer (19–23). This evidence concerns the gene MKI67 and intrahepatic cholangiocarcinoma.